"AVM0703 is a purer and loaded formulation of dexamethasone, which has been used at lower doses since 1958 for other purposes. Our supra-pharmacologic dose has a novel mechanism of action (MOA) to mobilize the body’s own natural supercharged immune cells that are ten times more activated than ordinary immune cells."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze